European Pharmaceutical Review

APRIL 8, 2024

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. The paper by Yoshiura et al. is a pre-print published by Research Square.

Manufacturing 52

Manufacturing Networking Pharmaceutical Marketing 52

PM360

OCTOBER 28, 2022

Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. Furthermore, these studies demonstrate how KAM must be treated not simply as a role or as a sales or market access initiative, but as an organization-wide business strategy.

Key account management 117

Key account management Pharma Management Pharma sales reps 117

Pharma Marketing Network

DECEMBER 17, 2021

While large corporations with mega campuses will start to “return to campus” in 2022, if they haven’t already, few are drawing hard lines around a full-time return. With every shot in the arm, we continue to dimmish the impact of COVID, but this pandemic will leave us with long-term societal effects. Pandemic Long-Haul.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Cadensee

JULY 26, 2021

And I learned about the clinical studies and the research that they're doing with supplements for children. And for many parents, and I know this was the case for me, it's not just about the centimeters, but it's also about having that sense that you're doing everything that you can for your child. We can have patents too.

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

JANUARY 10, 2023

Baxdrostat reduced systolic blood pressure in study subgroups, including Black/African American patients who make up approximately 81–89% of the hypertensive population in the US. Baral goes on to say such deals may be more common instead of the “mega mergers” of previous years. It outweighs the business case”. “We

Prospecting 98

Prospecting Pharma Pharmaceutical Competition 98